Shropshire professor appointed to world-leading fertility organisation
The head of fertility services at the trust that runs Shropshire’s two acute hospitals has been appointed by the government to the body that governs and regulates fertility treatment and research using human embryos.
As a member of the Human Fertilisation and Embryology Authority (HFEA), professor Jason Kasraie, consultant embryologist and head of fertility services at The Shrewsbury and Telford Hospital NHS Trust (SaTH), which runs the Shropshire and Mid Wales Fertility Centre, will play a vital role in helping to shape the future of fertility treatment, regulation and embryo research in the UK.
As part of his role Jason will also sit on the Scientific and Clinical Advances Advisory committee, which considers advances in science and clinical practice that are relevant to the authority's work.
A world class expert organisation in the fertility sector, the HFEA was the first statutory body of its type in the world.
Jason said: “It is a real honour to have been appointed as a member of the board of the HFEA. I’m really looking forward to working with colleagues on the board to help shape the future of assisted conception treatment and embryo and gamete research regulation.
“The position should be synergistic with my role as HFEA ‘Person Responsible’ for the service and help the team at SaTH to further strengthen regulatory compliance in assisted conception.”
Louise Barnett, chief executive at SaTH, said: “On behalf of the trust I would like to congratulate Jason on his appointment to the board of the HFEA.
"We are very proud of Jason’s achievement which will add great value to his role leading the Shropshire and Mid Wales Fertility Centre."
The Shropshire and Mid Wales Fertility Centre is an NHS assisted conception centre delivering the latest assisted conception methods and technology to both NHS and private patients.
The centre moved to its state-of-the-art facility at Severn Fields Health Village in Shrewsbury in 2018.
It was designed by its multi-professional fertility team to provide scope for more advanced fertility treatments, such as pre-implantation genetic diagnosis, to be offered in the future.
